Metabolic markers in breast cancer

Image Source-Google | Image by- | nature

Clinically, the maximum useful metabolic markers in breast cancer are the estrogen and progesterone receptors that are used to expect response to hormone therapy. New or probably new markers for breast most cancers consist of BRCA1 and BRCA2 to pick out humans at high risk of growing breast most cancers, HER-2, and SCD1, for predicting response to healing regimens, and urokinase plasminogen activator, PA1-1 and SCD1 for assessing prognosis.